-
Signature
-
/s/ Tyler Nielsen, by power of attorney
-
Issuer symbol
-
DNLI
-
Transactions as of
-
12 Aug 2025
-
Net transactions value
-
-$51,684
-
Form type
-
4
-
Filing time
-
14 Aug 2025, 20:33:05 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Ho Carole |
Chief Medical Officer |
C/O DENALI THERAPEUTICS INC., 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO |
/s/ Tyler Nielsen, by power of attorney |
14 Aug 2025 |
0001724605 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DNLI |
Common Stock |
Sale |
$39,884 |
-2,937 |
-1.3% |
$13.58 |
217,391 |
12 Aug 2025 |
Direct |
F1, F2, F3 |
| transaction |
DNLI |
Common Stock |
Sale |
$11,800 |
-806 |
-0.37% |
$14.64 |
216,585 |
13 Aug 2025 |
Direct |
F3, F4 |
| holding |
DNLI |
Common Stock |
|
|
|
|
|
183,219 |
12 Aug 2025 |
See footnote |
F5 |
| holding |
DNLI |
Common Stock |
|
|
|
|
|
25,000 |
12 Aug 2025 |
See footnote |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: